Achieving Product Launch Potential for Large Pharma
With the prevalence of cancers increasing, the treatment landscape has also shifted. Oncology drug launches are ever more critical and require a dedicated approach. For this reason, a large biotech and pharma company engaged Herspiegel Consulting for their product launch planning for a late oncology entrant in an established category.
A biotech and large pharma company partnered with Herspiegel Consulting to commercialize a new oncology asset. The launch teams needed a cohesive launch plan reflecting all activities to be completed for launch readiness.